Live Markets
Tuesday, July 28, 2026·George Town, KY·29°·Partly Cloudy
Markets Open · NYSE·Newsletter·Masthead·
VOL. XII · NO. 117Established MMXIV · George Town, Grand CaymanAtlantic Edition · $4.50

The Cayman Journal

Finance · Business · Technology · Caribbean & Global Affairs
Markets · Healthcare

Phibro Animal Health Corporation (PAHC)

NGM · Drug Manufacturers - Specialty & Generic

$36.37+1.13 (+3.21%)Quote refreshed

Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires

Market Cap
$1.48B
P/E (TTM)
15.09
EPS
$2.41
Div Yield
1.36%
52W Range
$25.58–$60.08
Beta
0.46

Company overview

Next earnings: 2026-08-26(29d)

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs. It also offers animal health products, such as antibacterials, anticoccidials, nutritional specialty, and vaccines and vaccine adjuvants for animal's health and performance, food safety, and animal welfare; and engages in developing, manufacturing, and marketing of microbial and bioproducts for various applications serving animal health and nutrition, environmental, industrial, and agricultural customers. In addition, the company develops, manufactures, and markets conventionally licensed and autogenous vaccine products, as well as adjuvants for animal vaccine manufacturers. Further, it provides formulations and concentrations of trace minerals, such as zinc, copper, manganese, iron, and other compounds to fortify the daily feed requirements of their livestock's diets and maintain optimal balance of trace elements in animals. Additionally, the company offers specialty ingredients for use in personal care, industrial chemical, and chemical catalyst industries. It sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle producers, as well as through commercial animal feed manufacturers, wholesalers, and distributors. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was incorporated in 1946 and is headquartered in Teaneck, New Jersey.

Peers in Drug Manufacturers - Specialty & Generic

All in industry →

Recent press releases

Phibro Animal Health Corporation has not issued a press release in this window.

SEC filings

All filings →

Phibro Animal Health Corporation has not filed an SEC document in this window.

Phibro Animal Health Corporation has no reported insider trades in the last 90 days.

Institutional holders

All holders →
As of 2025-12-31 · prior 2025-09-30
641,313 sh+4227.1%
3,345,487 sh-2.4%
209,800 sh● NEW
240,897 sh-39.7%
182,849 sh-32.2%
206,304 sh+324.7%

People at Phibro Animal Health Corporation

All people →

Quarterly financials

Full financials →
Revenue trend
12/24
$150.3M
NI $3.2M
03/25
$33.4M
NI $20.9M
09/25
$363.9M
NI $26.5M
RevenueNI = Net Income
EPS trend (diluted)
Latest: $0.65
Prior: $0.51
Revenue sparkline